1. Market Research
  2. > Healthcare
  3. > Diagnostics Market Trends
  4. > Italy Infectious Diagnostics Market Outlook to 2021

Italy Infectious Diagnostics Market Outlook to 2021

  • September 2015
  • -
  • Global Data
  • -
  • 37 pages

Italy Infectious Diagnostics Market Outlook to 2021

Summary

GlobalData’s new report, "Italy Infectious Diagnostics Market Outlook to 2021", provides key market data on the Italy Infectious Diagnostics market. The report provides value, in millions of US dollars within market segments - Hepatitis Viruses, Retroviruses, Infectious Diagnostics Multiple Parameters Panels, Bacteriology, Nucleic Acid Testing Instruments, Other Virology, Infectious Diagnostics Rapid Tests & POC and Parasitology & Mycology.

The report also provides company shares and distribution shares data for the market category, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is available in the report.

Extensive interviews are conducted with industry experts to validate the market size, company share and distribution share data and analysis.

Scope

- Infectious Diagnostics market includes Hepatitis Viruses, Retroviruses, Infectious Diagnostics Multiple Parameters Panels, Bacteriology, Nucleic Acid Testing Instruments, Other Virology, Infectious Diagnostics Rapid Tests & POC and Parasitology & Mycology.
- Annualized market revenues (USD million) data for each of the market categories. Data is provided from 2007 to 2014 and forecast to 2021.
- 2014 company shares and distribution shares data for Infectious Diagnostics market.
- Global corporate-level profiles of key companies operating within the Italy Infectious Diagnostics market.
- Key players covered include Siemens Healthcare, F. Hoffmann-La Roche Ltd., Abbott Laboratories, Hologic, Inc., Qiagen N.V., Becton, Dickinson and Company, Danaher Corporation and Alere Inc..

Reasons to buy

- Develop business strategies by identifying the key market segments poised for strong growth in the future.
- Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the market.
- Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
- What are the key distribution channels and what’s the most preferred mode of product distribution - Identify, understand and capitalize.

Table Of Contents

Italy Infectious Diagnostics Market Outlook to 2021
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 3
1.2 List of Figures 3
2 Introduction 4
2.1 What Is This Report About? 4
2.2 Infectious Diagnostics Market Segmentation 4
2.3 Definitions of Markets Covered in the Report 5
3 Infectious Diagnostics Market, Italy 7
3.1 Infectious Diagnostics Market, Italy, Revenue ($m), 2007-2014 7
3.2 Infectious Diagnostics Market, Italy, Revenue ($m), 2014-2021 9
3.2.1 Infectious Diagnostics Rapid Tests and POC Market, Italy, Revenue ($m), by Segment, 2007-2014 11
3.2.2 Infectious Diagnostics Rapid Tests and POC Market, Italy, Revenue ($m), by Segment, 2014-2021 13
3.3 Infectious Diagnostics Market, Italy, Distribution Share by Revenue ($m), 2013-2014 15
3.4 Infectious Diagnostics Market, Italy, Company Share by Revenue ($m), 2014 16
4 Overview of Key Companies in Italy, Infectious Diagnostics Market 18
4.1 F. Hoffmann-La Roche Ltd. 18
4.1.1 Company Overview 18
4.2 DiaSorin S.p.A 18
4.2.1 Company Overview 18
4.3 Abbott Laboratories 18
4.3.1 Company Overview 18
4.4 Qiagen N.V. 19
4.4.1 Company Overview 19
4.5 Siemens Healthcare 19
4.5.1 Company Overview 19
4.6 Becton, Dickinson and Company 19
4.6.1 Company Overview 19
4.7 Alere Inc. 20
4.7.1 Company Overview 20
4.8 bioMerieux S.A. 20
4.8.1 Company Overview 20
5 Infectious Diagnostics Market Pipeline Products 21
6 Financial Deals Landscape 33
6.1 Partnerships 33
6.1.1 Biocartis Enters into Licensing and Development Agreement with Microbiome 33
7 Appendix 34
7.1 Research Methodology 35
7.1.1 Coverage 35
7.1.2 Secondary Research 35
7.1.3 Primary Research 35
7.1.4 Company Share Analysis 36
7.1.5 Distribution Share Analysis 36
7.2 GlobalData Consulting 36
7.3 Contact Us 36
7.4 Disclaimer 37

1.1 List of Tables
Table 1: Infectious Diagnostics Market, Italy, Revenue ($m), USD Constant, Historic, 2007-2014 8
Table 2: Infectious Diagnostics Market, Italy, Revenue ($m), USD Constant, Forecast, 2014-2021 10
Table 3: Infectious Diagnostics Rapid Tests and POC Market, Italy, Revenue ($m), USD Constant, Historic, 2007-2014 12
Table 4: Infectious Diagnostics Rapid Tests and POC Market, Italy, Revenue ($m), USD Constant, Forecast, 2014-2021 14
Table 5: Infectious Diagnostics Market, Italy, Distribution Share by Revenue ($m), USD Constant, 2013-2014 15
Table 6: Infectious Diagnostics Market, Italy, Company Share by Revenue ($m), USD Constant, 2014 17
Table 7: Infectious Diagnostics Market Pipeline Products 21
Table 8: Biocartis Enters into Licensing and Development Agreement with Microbiome 33

1.2 List of Figures
Figure 1: Infectious Diagnostics Market, Italy, Revenue ($m), USD Constant, Historic, 2007-2014 7
Figure 2: Infectious Diagnostics Market, Italy, Revenue ($m), USD Constant, Forecast, 2014-2021 9
Figure 3: Infectious Diagnostics Rapid Tests and POC Market, Italy, Revenue ($m), USD Constant, Historic, 2007-2014 11
Figure 4: Infectious Diagnostics Rapid Tests and POC Market, Italy, Revenue ($m), USD Constant, Forecast, 2014-2021 13
Figure 5: Infectious Diagnostics Market, Italy, Company Share (%) 2014 16

Companies Mentioned
F. Hoffmann-La Roche Ltd.
DiaSorin S.p.A
Abbott Laboratories
Qiagen N.V.
Siemens Healthcare
Becton, Dickinson and Company
Alere Inc.
bioMerieux S.A.

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
2017 Europe Cancer Diagnostics Market: Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

2017 Europe Cancer Diagnostics Market: Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

  • $ 36000
  • Industry report
  • February 2017
  • by Venture Planning Group

This new 31-country report from VPGMarketResearch.com is available by country, market segment, section, or individual test. This report is designed to assist diagnostics industry executives, as well as ...

Cancer Diagnostics 2017-2021: US, Europe, Japan--Market Analysis, Competitive Intelligence, Technology Trends, Opportunities for Suppliers

Cancer Diagnostics 2017-2021: US, Europe, Japan--Market Analysis, Competitive Intelligence, Technology Trends, Opportunities for Suppliers

  • $ 21100
  • Industry report
  • December 2016
  • by Venture Planning Group

Complete report $34,750.  DataPack (test volumes, sales forecasts, supplier shares) $21,100. The report is available by country, section, market segment, and can be custom-tailored to your specific information ...

2017 Asia-Pacific Cancer Diagnostics Market: Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

2017 Asia-Pacific Cancer Diagnostics Market: Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

  • $ 11300
  • Industry report
  • February 2017
  • by Venture Planning Group

This new 17-country report from VPGMarketResearch.com is available by country, market segment, section, or individual test. This report is designed to assist diagnostics industry executives, as well as ...


ref:plp2015

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.